ProAssurance Co. (NYSE:PRA - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $23.63 and last traded at $23.19, with a volume of 4981 shares. The stock had previously closed at $23.28.
Analyst Upgrades and Downgrades
PRA has been the topic of several research reports. StockNews.com assumed coverage on ProAssurance in a report on Wednesday. They set a "hold" rating on the stock. Citizens Jmp downgraded ProAssurance from an "outperform" rating to a "market perform" rating in a report on Thursday, April 3rd. Raymond James cut shares of ProAssurance from a "market perform" rating to an "underperform" rating in a report on Thursday. Finally, Citigroup lowered shares of ProAssurance to a "market perform" rating in a report on Thursday, April 3rd. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $18.67.
Check Out Our Latest Analysis on ProAssurance
ProAssurance Price Performance
The firm has a market capitalization of $1.19 billion, a P/E ratio of 28.05 and a beta of -0.09. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. The stock's fifty day simple moving average is $18.20 and its 200 day simple moving average is $16.55.
ProAssurance (NYSE:PRA - Get Free Report) last posted its earnings results on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The company had revenue of $287.52 million during the quarter, compared to analysts' expectations of $274.56 million. On average, equities research analysts predict that ProAssurance Co. will post 0.8 EPS for the current year.
Institutional Trading of ProAssurance
Institutional investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its stake in ProAssurance by 4.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,703,953 shares of the insurance provider's stock valued at $43,019,000 after buying an additional 123,232 shares during the last quarter. State Street Corp raised its position in shares of ProAssurance by 1.8% in the 3rd quarter. State Street Corp now owns 1,968,754 shares of the insurance provider's stock valued at $29,610,000 after purchasing an additional 34,247 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in ProAssurance by 0.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,316,249 shares of the insurance provider's stock worth $20,678,000 after purchasing an additional 4,814 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in ProAssurance by 92.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 690,871 shares of the insurance provider's stock worth $10,992,000 after purchasing an additional 331,224 shares during the last quarter. Finally, Janus Henderson Group PLC increased its stake in ProAssurance by 2,655.2% during the 4th quarter. Janus Henderson Group PLC now owns 645,358 shares of the insurance provider's stock valued at $10,268,000 after purchasing an additional 621,935 shares in the last quarter. Institutional investors and hedge funds own 85.58% of the company's stock.
About ProAssurance
(
Get Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Read More
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
